Biogen (BIIB) FCF Margin (2009 - 2026)
Biogen (BIIB) posted FCF Margin of 14.91% for Q2 2026, down 37.83% on a QoQ basis from 23.98% in Q1 2026, and up 984.0% year-over-year from 1.38% in Q2 2025.
Powered by 
Analysis
Biogen (BIIB) FCF Margin (2009 - 2026) Analysis & Trends
Biogen has reported FCF Margin for 18 years, with the latest figure at 14.91% in Q2 2026.
- On a quarterly basis, FCF Margin rose 984.0% year-over-year to 14.91% in Q2 2026; TTM through Jun 2026 was 26.89%, a 710.0% increase from a year earlier, with the FY2025 full-year figure at 20.73%, down 739.0% from the prior year.
- FCF Margin was 14.91% for Q2 2026 at Biogen, down from 23.98% in the prior quarter.
- The five-year high for FCF Margin was 48.38% in Q3 2025, with the low at 10.28% in Q4 2022.
- Average FCF Margin over 5 years is 18.33%, with a median of 20.51% recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: FCF Margin tumbled 3905 bps in 2022, then jumped 3161 bps in 2024.
- Over 5 years, FCF Margin stood at 10.28% in 2022, then surged by 79 bps to 2.21% in 2023, then jumped by 1431 bps to 29.4% in 2024, then tumbled by 30 bps to 20.53% in 2025, then decreased by 27 bps to 14.91% in 2026.
- The last three FCF Margin figures came in at 14.91% (Q2 2026), 23.98% (Q1 2026), and 20.53% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 14.91% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -18,629.40% |
| 10 | Insmed | 27.67 Bn | 26.51 Bn | 358.27 Mn | -22.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.91% |
| Mar 31, 2026 | 23.98% |
| Dec 31, 2025 | 20.53% |
| Sep 30, 2025 | 48.38% |
| Jun 30, 2025 | 5.08% |
| Mar 31, 2025 | 9.14% |
| Dec 31, 2024 | 29.40% |
| Sep 30, 2024 | 36.52% |
| Jun 30, 2024 | 24.03% |
| Mar 31, 2024 | 22.15% |
| Dec 31, 2023 | -2.21% |
| Sep 30, 2023 | 20.48% |
| Jun 30, 2023 | 16.94% |
| Mar 31, 2023 | 15.78% |
| Dec 31, 2022 | -10.28% |
| Sep 30, 2022 | 23.99% |
| Jun 30, 2022 | 27.02% |
| Mar 31, 2022 | 4.10% |
| Dec 31, 2021 | 28.78% |
| Sep 30, 2021 | 27.47% |